icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
Digital Experience
AASLD
November 13 - 16 - 2020
Back grey_arrow_rt.gif
 
 
 
Safety and Drug-Drug Interaction of Tropifexor in Combination With Licogliflozin in Healthy but Overweight to Obese Subjects in Support of a Ph2b Combination Study ELIVATE
 
 
  AASLD 2020 Nov 11-16
Reported by Jules Levin
 
Jessie Gu1, Markus Weiss2, Wendy Weis3, Bharti Shah3, William Prince1, Jin Chen3, Ralph Woessner2, Chinweike Ukomadu1, Felicity Schaefer3, and Patricia Lopez4 1Novartis Institutes for Biomedical Research, Cambridge, USA; 2Novartis Institutes for Biomedical Research, Basel, Switzerland; 3Novartis Pharmaceuticals Corporation, East Hanover, USA; 4Novartis Pharma AG, Basel, Switzerland

1124201

1124202

1124203

1124204

1124205